How to Lower Triglyceride Levels
For elevated triglycerides, prioritize lifestyle modifications first—targeting 5-10% weight loss, eliminating added sugars and alcohol, and engaging in at least 150 minutes weekly of moderate-intensity aerobic exercise—which can reduce triglycerides by 20-70%; however, if triglycerides reach ≥500 mg/dL, immediately initiate fenofibrate therapy to prevent acute pancreatitis before addressing any other lipid abnormalities. 1, 2
Classification-Based Treatment Algorithm
The approach to lowering triglycerides depends critically on the severity of elevation, as different thresholds carry distinct risks and require different interventions:
Mild to Moderate Hypertriglyceridemia (150-499 mg/dL)
Lifestyle interventions are the cornerstone of initial management:
Weight loss is the single most effective intervention—a 5-10% reduction in body weight produces a 20% decrease in triglycerides, with some patients achieving reductions up to 50-70%. 2, 3
Dietary modifications should include:
- Restricting added sugars to <6% of total daily calories and eliminating sugar-sweetened beverages, pastries, desserts, and candy completely. 1, 2, 3
- Limiting total fat to 30-35% of total calories for this triglyceride range. 1, 2, 3
- Prioritizing low-carbohydrate diets over low-fat diets, as they are more effective at lowering triglycerides. 1, 3
- Replacing saturated fats with polyunsaturated fatty acids (PUFAs), which lowers triglycerides by 0.4 mg/dL per 1% energy substitution. 3
- Increasing soluble fiber to 10-25 g/day. 3
- Consuming ≥2 servings (8+ ounces) per week of fatty fish like salmon, trout, sardines, or anchovies. 1, 3
Physical activity: Engage in at least 150 minutes per week of moderate-intensity or 75 minutes per week of vigorous-intensity aerobic activity, which reduces triglycerides by approximately 11%. 1, 2, 3
Alcohol restriction: Limit or completely avoid alcohol, as even 1 ounce per day corresponds to a 5-10% higher triglyceride concentration. 1, 2
Pharmacologic therapy considerations:
If 10-year ASCVD risk is ≥7.5% or LDL-C is also elevated, initiate or intensify statin therapy, which provides 10-30% dose-dependent triglyceride reduction. 2, 4
If triglycerides remain >200 mg/dL after 3 months of optimized lifestyle modifications and statin therapy, add prescription omega-3 fatty acids (icosapent ethyl 2-4 g/day) for patients with established cardiovascular disease or diabetes with ≥2 additional risk factors. 2, 4, 5
Severe Hypertriglyceridemia (500-999 mg/dL)
This level requires immediate pharmacologic intervention to prevent acute pancreatitis:
Initiate fenofibrate 54-160 mg daily immediately as first-line therapy before addressing LDL cholesterol, as fibrates provide 30-50% triglyceride reduction. 1, 2, 6
Do not start with statin monotherapy when triglycerides are ≥500 mg/dL, as statins provide only 10-30% triglyceride reduction and are insufficient for preventing pancreatitis at this level. 2, 6
Implement aggressive dietary fat restriction to 20-25% of total calories. 1, 2, 6
Completely eliminate all added sugars and alcohol, as alcohol can precipitate hypertriglyceridemic pancreatitis at these levels. 1, 6
Aggressively evaluate and treat secondary causes, particularly uncontrolled diabetes mellitus, as optimizing glucose control can dramatically reduce triglycerides independent of lipid medications. 1, 2, 6
Once triglycerides fall below 500 mg/dL, reassess LDL-C and initiate or optimize statin therapy if LDL-C is elevated or cardiovascular risk is high. 2, 6
Very Severe Hypertriglyceridemia (≥1,000 mg/dL)
This represents a medical emergency requiring extreme measures:
Implement extreme dietary fat restriction to 10-15% of total calories (or <5% in some cases) until triglycerides fall below 1,000 mg/dL. 1, 2
Maintain fenofibrate therapy at maximum doses (54-200 mg daily). 2
Consider adding prescription omega-3 fatty acids (2-4 g/day) as adjunctive therapy. 1, 2
Patients at this level have a 14% incidence of acute pancreatitis, with risk escalating dramatically as levels approach or exceed 1,000 mg/dL. 1, 6
Critical Assessment of Secondary Causes
Before or concurrent with treatment, evaluate for:
Uncontrolled diabetes mellitus—often the primary driver of severe hypertriglyceridemia; optimizing glycemic control may be more effective than additional lipid medications. 1, 2, 6
Hypothyroidism, renal disease, liver disease—all can significantly elevate triglycerides. 2
Medications that raise triglycerides: thiazide diuretics, beta-blockers, estrogen therapy, corticosteroids, antiretrovirals, and antipsychotics should be discontinued or substituted if possible. 2
Excessive alcohol intake—alcohol synergistically increases triglycerides when coupled with meals high in saturated fat, impairing chylomicron hydrolysis and increasing VLDL production. 1
Combination Therapy Safety Considerations
When combining fenofibrate with statins (which may be necessary once triglycerides are controlled):
Use lower statin doses to minimize myopathy risk, particularly in patients >65 years or with renal disease. 2, 6
Fenofibrate has a better safety profile than gemfibrozil when combined with statins; gemfibrozil should be avoided. 2
Monitor creatine kinase levels and muscle symptoms, especially in high-risk patients. 2
Monitoring Strategy
Reassess fasting lipid panel in 4-8 weeks after implementing lifestyle modifications or initiating pharmacotherapy. 2, 3
For patients with diabetes or prediabetes, monitor HbA1c every 3 months until target levels are reached. 3
Monitor liver enzymes (AST/ALT) at baseline, 3 months, then annually when using fibrates. 2
Common Pitfalls to Avoid
Delaying fibrate initiation while attempting lifestyle modifications alone in patients with triglycerides ≥500 mg/dL—pharmacologic therapy is mandatory at this level. 2, 6
Starting with statins alone for severe hypertriglyceridemia—fibrates or niacin must be initiated first to prevent pancreatitis. 2, 4
Ignoring secondary causes—particularly uncontrolled diabetes, which can lead to unnecessary medication escalation. 2, 6
Using over-the-counter fish oil supplements instead of prescription omega-3 fatty acids—they are not equivalent and should not be substituted. 2
Combining high-dose statins with fibrates without dose adjustment—this significantly increases myopathy risk. 2, 6